Skip to main content
AIOBIO Co., Ltd. logo

AIOBIO Co., Ltd. — Investor Relations & Filings

Ticker · 447690 ISIN · KR7447690009 KO Manufacturing
Open in API
Filings indexed 88 across all filing types
Latest filing 2025-09-05 Major Shareholding Noti…
Country KR South Korea
Listing KO 447690

About AIOBIO Co., Ltd.

https://www.aiobio.com/

AIOBIO Co., Ltd. is a medical device company specializing in advanced dental care solutions. The company develops and manufactures diagnostic tools and platforms based on its proprietary Biofluorescence-Led Intelligent Screening System (BLISS) technology. Its product portfolio includes imaging devices that provide instant visual analysis for the early detection of oral health issues. AIOBIO's core offering is the LINKDENS platform, an integrated system that connects dental clinics and patients. Powered by AI-driven diagnostics, instant imaging analysis, and remote patient monitoring, LINKDENS streamlines clinical workflows, enhances diagnostic accuracy, and fosters a connected dental care experience for both professionals and patients.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details changes in share ownership by DSC Investment Inc. in the company IO Bio. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership thresholds and changes in shareholding status.
2025-09-05 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (증권선물위원회) and the Korea Exchange. This is a standard regulatory filing in South Korea used to disclose changes in shareholdings by major shareholders or insiders. While it involves a major shareholder (DSC Investment), it is specifically a report on the ownership status of an insider/major shareholder rather than a general 'Major Shareholding Notification' (MRQ) which typically refers to the 5% rule filings. Given the specific nature of insider/major shareholder reporting in the Korean regulatory context, it fits best under 'Director's Dealing' (DIRS) as it reports the personal/entity share transactions of a major shareholder/insider.
2025-09-05 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details a change in shareholding (specifically due to the acquisition of convertible bonds) by a major shareholder, (주)에이앤아이, in the company (주)아이오바이오. This falls under the category of Major Shareholding Notification.
2025-07-11 Korean
증권발행결과(자율공시) (제4회차 CB)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the 'Result of Securities Issuance' (증권 발행결과) for a private placement of convertible bonds (CB). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of new debt/equity instruments.
2025-07-10 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Financial Supervisory Service (금융위원회) in South Korea. It specifically details the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정), including terms, interest rates, conversion prices, and the use of proceeds. This type of regulatory filing regarding capital structure changes and financing activities is classified as a Capital/Financing Update.
2025-07-08 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) held on June 18, 2025. It lists specific agenda items (stock option grants and extensions) and their voting outcomes (rejected or approved). This falls under the category of Declaration of Voting Results.
2025-06-18 Korean

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.